For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
9
views
21
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A case of congenital single testis with testicular cancer patient and azoospermia who was able to collect spermatozoa with ipsilateral Onco‐TESE

      case-report

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Onco‐TESE is a useful strategy for cancer patients with a congenital single testis who wish to preserve their fertility.

          Abstract

          Onco‐TESE is a useful strategy for cancer patients with a congenital single testis who wish to preserve their fertility.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update

          Erica Wang, Alison Loren, Joyce D Reinecke … (2018)
          Purpose To provide current recommendations about fertility preservation for adults and children with cancer. Methods A systematic review of the literature published from January 2013 to March 2017 was completed using PubMed and the Cochrane Library. An Update Panel reviewed the identified publications. Results There were 61 publications identified and reviewed. None of these publications prompted a significant change in the 2013 recommendations. Recommendations Health care providers should initiate the discussion on the possibility of infertility with patients with cancer treated during their reproductive years or with parents/guardians of children as early as possible. Providers should be prepared to discuss fertility preservation options and/or to refer all potential patients to appropriate reproductive specialists. Although patients may be focused initially on their cancer diagnosis, providers should advise patients regarding potential threats to fertility as early as possible in the treatment process so as to allow for the widest array of options for fertility preservation. The discussion should be documented. Sperm, oocyte, and embryo cryopreservation are considered standard practice and are widely available. There is conflicting evidence to recommend gonadotrophin-releasing hormone agonists (GnRHa) and other means of ovarian suppression for fertility preservation. The Panel recognizes that, when proven fertility preservation methods are not feasible, and in the setting of young women with breast cancer, GnRHa may be offered to patients in the hope of reducing the likelihood of chemotherapy-induced ovarian insufficiency. GnRHa should not be used in place of proven fertility preservation methods. The panel notes that the field of ovarian tissue cryopreservation is advancing quickly and may evolve to become standard therapy in the future. Additional information is available at www.asco.org/survivorship-guidelines .
          Article 0 comments Cited 393 times – based on 0 reviews     Review now
            • Record: found
            • Abstract: found
            • Article: not found

            Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects.

            N E Skakkebaek, E. Rajpert-De Meyts, K M Main (2001)
            Numerous reports have recently focused on various aspects of adverse trends in male reproductive health, such as the rising incidence of testicular cancer; low and probably declining semen quality; high and possibly increasing frequencies of undescended testis and hypospadias; and an apparently growing demand for assisted reproduction. Due to specialization in medicine and different ages at presentation of symptoms, reproductive problems used to be analysed separately by various professional groups, e.g. paediatric endocrinologists, urologists, andrologists and oncologists. This article summarizes existing evidence supporting a new concept that poor semen quality, testis cancer, undescended testis and hypospadias are symptoms of one underlying entity, the testicular dysgenesis syndrome (TDS), which may be increasingly common due to adverse environmental influences. Experimental and epidemiological studies suggest that TDS is a result of disruption of embryonal programming and gonadal development during fetal life. Therefore, we recommend that future epidemiological studies on trends in male reproductive health should not focus on one symptom only, but be more comprehensive and take all aspects of TDS into account. Otherwise, important biological information may be lost.
            Article 0 comments Cited 109 times – based on 0 reviews     Review now
              • Record: found
              • Abstract: found
              • Article: not found

              Physician referral for fertility preservation in oncology patients: a national study of practice behaviors.

              P. Jacobsen, T Albrecht, JOHNATHAN LANCASTER … (2009)
              Cancer survival rates are improving, and the focus is moving toward quality survival. Fertility is a key aspect of quality of life for cancer patients of childbearing age. Although cancer treatment may impair fertility, some patients may benefit from referral to a specialist before treatment. However, the majority of studies examining patient recall of discussion and referral for fertility preservation (FP) show that less than half receive this information. This study examined the referral practices of oncologists in the United States. This study examined oncologists' referral practice patterns for FP among US physicians using the American Medical Association Physician Masterfile database. A 53-item survey was administered via mail and Internet to a stratified random sample of US physicians. Forty-seven percent of respondents routinely refer cancer patients of childbearing age to a reproductive endocrinologist. Referrals were more likely among female physicians (P = .004), those with favorable attitudes (P = .043), and those whose patients routinely ask about FP (odds ratio = 2.09; 95% CI, 1.31 to 3.33). Less than half of US physicians are following the guidelines from the American Society of Clinical Oncology, which suggest that all patients of childbearing age should be informed about FP.
              Article 0 comments Cited 94 times – based on 0 reviews     Review now
                All references

                Author and article information

                Contributors
                Kazumasa Hayashi:
                ORCID: https://orcid.org/0000-0002-1807-0256
                uro063@osaka-med.ac.jp
                Journal
                Journal ID (nlm-ta): Clin Case Rep
                Journal ID (iso-abbrev): Clin Case Rep
                Journal ID (doi): 10.1002/(ISSN)2050-0904
                Journal ID (publisher-id): CCR3
                Title: Clinical Case Reports
                Publisher: John Wiley and Sons Inc. (Hoboken )
                ISSN (Electronic): 2050-0904
                Publication date (Electronic): 23 November 2020
                Publication date Collection: January 2021
                Volume: 9
                Issue: 1 ( doiID: 10.1002/ccr3.v9.1 )
                Pages: 535-539
                Affiliations
                [ 1 ] Department of Urology Ishinkai Yao Sogo Byoin Yao Japan
                [ 2 ] Department of Urology Osaka Medical College Takatsuki Japan
                [ 3 ] Department of Urology Tesseikai Neurosurgical Hospital Shijyounawate Japan
                [ 4 ] Department of Urology Ladies Clinic Kitahama Osaka Japan
                Author notes
                [*] [* ] Correspondence

                Kazumasa Hayashi, Department of Urology, Ishinkai Yao Sogo Byoin, Yao, Osaka, Japan.

                Email: uro063@ 123456osaka-med.ac.jp

                Author information
                https://orcid.org/0000-0002-1807-0256
                https://orcid.org/0000-0002-1351-1315
                Article
                Publisher ID: CCR33576
                DOI: 10.1002/ccr3.3576
                PMC ID: 7813069
                SO-VID: 35496f07-848c-45c3-b433-f42879734376
                Copyright © © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
                License:

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                Date received : 21 August 2020
                Date revision received : 22 October 2020
                Date accepted : 01 November 2020
                Page count
                Figures: 6, Tables: 0, Pages: 0, Words: 2284
                Categories
                Subject: Case Report
                Subject: Case Reports
                Custom metadata
                source-schema-version-number 2.0
                cover-date January 2021
                details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.6 mode:remove_FC converted:18.01.2021

                Keywords: cancer patient,congenital single testis,onco‐tese,testicular cancer
                Data availability:
                Keywords: cancer patient, congenital single testis, onco‐tese, testicular cancer

                Comments

                Comment on this article

                Related Documents Log